Open Call:
Therapeutics for New Drug Development
Commercialise Your Innovations with Celltrion, a Global Biopharma Leader
About Celltrion
​
Celltrion is a global biopharmaceutical leader with deep expertise in drug development and biologics manufacturing. The company is actively seeking innovations for new drug development to advance healthcare solutions. With a proven track record of successful collaborations, including partnerships with Pinot Bio and Abpro, Celltrion is eager to work with innovators who are ready to take their solutions to the next level.
This is your opportunity to collaborate with Celltrion through co-development, investment, licensing, and commercialisation pathways, bringing your breakthrough innovations to a global audience.
​
​​​Focus Area 1: Antibody Oncology Therapeutics
​
Celltrion is actively seeking cutting-edge oncology-focused antibody therapeutic innovations. We are particularly interested in novel approaches that leverage the power of antibody engineering to target cancer more effectively. This includes new antibody modalities, conjugate platforms, and next-generation targeted delivery systems.
Deadline to Apply: 30 June 2025
Focus Area 2: Peptide-based Therapies
​
Celltrion is expanding its innovation landscape to include next-generation peptide-based therapies in either immunology or metabolic diseases, sarcopenia. We are actively scouting for advanced peptide technologies that address unmet medical needs through novel delivery methods, enhanced pharmacological profiles, and targeted therapeutic action.
Deadline to Apply: 30 June 2025
​
​Focus Area 3: Nucleic Acid Therapeutics
​
Celltrion is seeking transformative innovations in nucleic acid therapeutics (NATs) to address critical unmet needs in oncology and metabolic diseases. We are particularly interested in siRNA, antisense oligonucleotides, and mRNA platforms designed to either inhibit or stimulate specific protein expression. Technologies that demonstrate improved efficacy, extended half-life, and optimised delivery are highly encouraged.
Deadline to Apply: 30 June 2025
​
​Focus Area 4: Drug Delivery Systems
​
Celltrion is seeking cutting-edge drug delivery system (DDS) innovations that enable precise, tissue- or cell-selective therapeutic targeting in immunology and inflammatory disease. We are especially interested in lipid- and polymer-based nanoparticle platforms that enhance delivery efficiency, reduce systemic toxicity, and optimise therapeutic outcomes.
Deadline to Apply: 30 June 2025